Equity |
3 Months Ended |
|---|---|
Mar. 31, 2026 | |
| Equity | |
| Equity | 10. Equity In February 2024, the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with certain institutional accredited investors (the “Investors”), pursuant to which the Company issued and sold to the Investors in a private placement an aggregate of 32,413,560 shares of the Company’s common stock, par value $0.0001 per share (the “Shares”), at a price of $7.52 per share, and, to certain Investors in lieu of Shares, pre-funded warrants to purchase 10,805,957 shares of the Company’s common stock (the “Pre-Funded Warrants”), at a price of $7.519 per Pre-Funded Warrant (the “2024 Private Placement”). Each Pre-Funded Warrant issued in the 2024 Private Placement that remains outstanding has an exercise price of $0.001 per share, is currently exercisable and will remain exercisable until the Pre-Funded Warrant is exercised in full. During the three months ended March 31, 2026, Pre-Funded Warrants to purchase 1,749,453 shares of the Company’s common stock were exercised via cashless exercise for 1,749,300 shares of the Company’s common stock. As of March 31, 2026, 5,818,592 Pre-Funded Warrants remained outstanding. There were no exercises of Pre-Funded Warrants during the three months ended March 31, 2025.
|